Skip to main content
Biochemistry and Biophysics Reports logoLink to Biochemistry and Biophysics Reports
. 2021 Jan 6;25:100900. doi: 10.1016/j.bbrep.2020.100900

Erratum regarding missing Declaration of Competing Interest statements in previously published articles

PMCID: PMC7880918  PMID: 33614994

Declaration of Competing Interest statements were not included in the published version of the following articles that appeared in previous issues of Biochemistry and Biophysics Reports

The appropriate Declaration/Competing Interest statements, provided by the Authors, are included below.

  • 1.

    “The mouse–canine chimeric anti-dog podoplanin antibody P38B exerts antitumor activity in mouse xenograft models” [Biochemistry and Biophysics Reports, 2018; 17C; 590] https://10.1016/j.bbrep.2018.11.005

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.

  • 3.

    “Effective anti-cancer property of Pouteria sapota leaf on breast cancer cell lines” [Biochemistry and Biophysics Reports, 2018; 15C: 547] DOI – https://10.1016/j.bbrep.2018.06.004

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.

  • 4.

    “A method to induce hen egg lysozyme-specific humoral immune tolerance in mice by pre-exposition with the protein's oligomers” [Biochemistry and Biophysics Reports, 2019; 20C: 100679] DOI – https://10.1016/j.bbrep.2019.100679

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.

  • 5.

    “Insulin down-regulates cardioprotective SUR2A in the heart-derived H9c2 cells: A possible explanation for some adverse effects of insulin therapy” [Biochemistry and Biophysics Reports, 2018; 16C: 563] DOI – https://10.1016/j.bbrep.2018.08.005

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.

  • 6.

    “Improvement of antibody affinity by introduction of basic amino acid residues into the framework region” [Biochemistry and Biophysics Reports,2018; 15C: 555] DOI – https://10.1016/j.bbrep.2018.07.005

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.

  • 7.

    “Rapamycin suppresses postnatal muscle hypertrophy induced by myostatin-inhibition accompanied by transcriptional suppression of the Akt/mTOR pathway” [Biochemistry and Biophysics Reports, 2018; 17C: 605] DOI – https://10.1016/j.bbrep.2018.12.009

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.

  • 8.

    “Comparison of autophagy inducibility in various tyrosine kinase inhibitors and their enhanced cytotoxicity via inhibition of autophagy in cancer cells in combined treatment with azithromycin” [Biochemistry and Biophysics Reports, 2020; 22C: 100750] DOI – https://10.1016/j.bbrep.2020.100750

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.

  • 9.

    “Von Willebrand Factor Type A domain of hCLCA1 is sufficient for U-937 macrophage activation” [Biochemistry and Biophysics Reports, 2019; 18C: 100630] DOI – https://10.1016/j.bbrep.2019.100630

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.

  • 10.

    “Low level electricity increases the secretion of extracellular vesicles from cultured cells” [Biochemistry and Biophysics Reports, 2019; 21C: 100713] DOI – https://10.1016/j.bbrep.2019.100713

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.

  • 11.

    “Tea extract increases cell fusion via regulation of cell surface DC-STAMP” [Biochemistry and Biophysics Reports, 2020; 22C: 100759] https://10.1016/j.bbrep.2020.100759

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.

  • 12.

    “Crystal structure of 6aJL2-R24G light chain variable domain: Does crystal packing explain amyloid fibril formation?” [Biochemistry and Biophysics Reports, 2019; 20C: 100682] https://10.1016/j.bbrep.2019.100682

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.

  • 13.

    “G790del mutation in DSC2 alone is insufficient to develop the pathogenesis of ARVC in a mouse model” [Biochemistry and Biophysics Reports, 2019; 21C: 100711] https://0.1016/j.bbrep.2019.100711

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.

  • 14.

    “Modulation of B cell activation threshold mediated by BCR/CD40 costimulation by targeting Cbl-b for ubiquitination” [Biochemistry and Biophysics Reports; 2019; 18C: 100641] DOI- https://10.1016/j.bbrep.2019.100641

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.

  • 15.

    “Analysis of the substrate recognition state of TDP-43 to single-stranded DNA using fluorescence correlation spectroscopy” [Biochemistry and Biophysics Reports, 2018; 14C: 520] https://10.1016/j.bbrep.2018.03.009

Declaration of competing interest: The authors were contacted after publication to request a Declaration of Interest statement.


Articles from Biochemistry and Biophysics Reports are provided here courtesy of Elsevier

RESOURCES